Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
2019
Sequencing of
circulating tumor DNAfrom cancer patients is a
cost-efficientapproach with
turnaround timecompatible with
clinical practiceto inform treatment decision-making in a phase 1 trial setting
Keywords:
-
Correction
-
Source
-
Cite
-
Save
26
References
115
Citations
NaN
KQI